Lung Tumours Can Shapeshift to Dodge Treatment, Study Reveals

A Cancer That Changes Its Stripes

A groundbreaking study published in Cell Reports Medicine has revealed that some lung tumours can actively change their identity as they evolve, shifting between different cancer types in ways that make them far harder to treat.

The research, co-led by the Institute for Systems Biology in Seattle and Fudan University, focused on combined small-cell lung cancer, a rare and aggressive disease where tumours contain features of both small-cell and non-small-cell lung cancer. These mixed tumours are frequently misclassified, leading to worse patient outcomes.

One Ancestor, Many Faces

Using cutting-edge spatial genomics and single-cell analysis, the team discovered that these tumours do not arise from two separate cancers colliding. Instead, they originate from a single ancestral cancer cell that branches into distinct identities over time. Roughly one-third of the small-cell-like tumour cells analysed existed in intermediate hybrid states, carrying features of multiple cancer types simultaneously.

The study also found that different regions within the same tumour create distinct microenvironments. Some areas were rich in immune cells, whilst others were largely shielded from immune attack by dense bands of connective-tissue cells called fibroblasts.

A New Diagnostic Tool

Because standard biopsies often sample only one region of a tumour, the mixed nature of the disease frequently goes undetected. To address this, the researchers developed a four-gene diagnostic tool that can identify hidden mixed identities even from limited biopsy samples. When applied to existing datasets, the tool flagged a higher proportion of combined cases than traditional pathology estimates, suggesting the disease may be significantly more common than currently recognised.

The findings underscore a growing recognition in oncology that cancer is not a static disease but a dynamic, evolving system that demands equally adaptive treatment strategies.